Cargando…
Gene Therapy and Hemophilia: Where Do We Go from Here?
Gene therapy for hemophilia using adeno-associated virus (AAV) derived vectors can reduce or eliminate patients’ disease-related complications and improve their quality of life. Broad implementation globally will lead to societal gains and foster health equity. Several vector products each for facto...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550170/ https://www.ncbi.nlm.nih.gov/pubmed/36226233 http://dx.doi.org/10.2147/JBM.S371438 |